ChoRe

A device for trans-catheter chordae tendineae repair

Journal Article (2019)
Author(s)

C. Culmone (TU Delft - Medical Instruments & Bio-Inspired Technology)

A. Ali (TU Delft - Medical Instruments & Bio-Inspired Technology)

Marta Scali (TU Delft - Medical Instruments & Bio-Inspired Technology)

Arianna Menciassi (Scuola Superiore Sant’Anna)

P. Breedveld (TU Delft - Medical Instruments & Bio-Inspired Technology)

Research Group
Medical Instruments & Bio-Inspired Technology
Copyright
© 2019 C. Culmone, A. Ali, M. Scali, Arianna Menciassi, P. Breedveld
DOI related publication
https://doi.org/10.1177/0954411919848856
More Info
expand_more
Publication Year
2019
Language
English
Copyright
© 2019 C. Culmone, A. Ali, M. Scali, Arianna Menciassi, P. Breedveld
Research Group
Medical Instruments & Bio-Inspired Technology
Issue number
7
Volume number
233
Pages (from-to)
712-722
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

This work focuses on the design of a new device (called ChoRe) to place artificial chords in the mitral valve structure during a trans-catheter procedure. The aim of the device is to restore the correct functionality of the valve and solve mitral valve regurgitation, that is, a common consequence of chordae tendineae rupture. An analysis of the requirements was carried out and used to design and develop a first functional prototype. The resulting device was able to connect artificial chords at the posterior leaflet of the mitral valve and at the apex of the left ventricle, also allowing the control of the artificial chord length. The ChoRe was tested ex-vivo in bovine hearts. The qualitative assessment of the ChoRe focused on the performance of the device and preliminary evaluation of the procedure time. Results demonstrated that the device is able to create a top and bottom fixation in an average time of 3.45 ± 1.44 min. Future improvements will focus on enhancing the connection at the leaflet, as well as the overall functionality, in order to guarantee better control of the artificial chord length. This work shows future potentials for more patient-specific treatments in trans-catheter scenarios for mitral valve repair.